- /
- Supported exchanges
- / MU
- / HUM.MU
Humana Inc (HUM MU) stock market data APIs
Humana Inc Financial Data Overview
There is no Profile data available for HUM.MU.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Humana Inc data using free add-ons & libraries
Get Humana Inc Fundamental Data
Humana Inc Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Humana Inc News
New
Humana Healthy Horizons in Oklahoma Selects Six Nonprofits to Receive Community Impact Awards
Funds will be used to address Oklahomans’ most urgent health-related social needs OKLAHOMA CITY, December 10, 2025--(BUSINESS WIRE)--Humana Healthy Horizons in Oklahoma has awarded six community-ba...
Behind the Curtain: How UnitedHealth is Rewriting its Own Rules
UnitedHealth Group Inc. UNH is quietly transforming its business playbook, pushing against the usual ways of delivering care and insurance. By merging insurance coverage with health services and cutti...
Did Humana’s Lowered Outlook and Mark Cuban Drug Talks Just Shift Humana's (HUM) Investment Narrative?
Earlier this month, Humana cut its full-year earnings outlook, citing ongoing pressure in its Medicare Advantage business amid a challenging reimbursement and cost backdrop. At the same time, attentio...
Plus Therapeutics Announces Expansion of CNSide Team and Issuance of Inducement Grants
Plus Therapeutics Inc. HOUSTON, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targeted...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.